glp-1 drugs news today Drugs: 6 Things We've Learned About Their Effects GLP-1 drugs like Ozempic linked

Studies, including a 2022 trial on semaglutide, have shown that patients can regain a significant portion of their lost weight after discontinuing the medication

Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials To view or add a comment, sign in More Relevant Posts The upheaval of the Health and Human Services workforce and leadership leaves much to be desired in terms of delivery, recently retired FDA Chief Information Officer Vid Desai tells BioSpace, but the regulatory agency is evolving to be more open to much needed change

Aspirations during anesthesia can lead to severe complications such as pneumonia, with factors like a full stomach, compromised protective airway reflexes, and reduced consciousness, thus theoretically heightening the risk in patients taking GLP-1 medications compared with the general population

But a different study published in August had the opposite findingit noted a reduction in the risk of those outcomes among women who had taken the drugs before becoming pregnant

5 Medications that inhibit DPP-4 work by slowing the degradation of incretins, subsequently sustaining GLP-1 and GIP activity

Understanding the Mounjaro vs Trulicity comparison helps patients make informed treatment decisions